Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-45
Closed -$10.6K 7598
2024
Q4
$10.6K Buy
+45
New +$14K ﹤0.01% 6383
2024
Q2
Hold
0
7624
2024
Q1
Hold
0
7720
2022
Q2
Sell
-2
Closed -$11K 6733
2022
Q1
$11K Buy
+2
New +$21.9K ﹤0.01% 6190
2021
Q1
Sell
-54
Closed -$1.21M 6241
2020
Q4
$1.21M Sell
54
-4
-7% -$96.1K ﹤0.01% 3835
2020
Q3
$1.53M Buy
58
+42
+263% +$1.14M ﹤0.01% 3403
2020
Q2
$445K Hold
16
﹤0.01% 3902
2020
Q1
$453K Buy
16
+15
+1,500% +$413K ﹤0.01% 3864
2019
Q4
$20K Buy
+1
New +$33.9K ﹤0.01% 5317

Other funds holding NCNA

JP Morgan Chase's NCNA Position: Q1 2025 in Review

JP Morgan Chase sold out of NuCana (NCNA) in Q1 2025, closing a stake of 45 shares — an estimated $10.6K sold.

JP Morgan Chase first reported a position in NCNA in Q4 2019 and held it in 7 quarters. The position peaked at $1.53M in Q3 2020. 10 funds tracked by Wall St. Rank hold NCNA as of Q1 2025.

  • JP Morgan Chase reported no remaining NuCana position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 45 NuCana shares in Q1 2025, an estimated $10.6K.
  • JP Morgan Chase first reported a position in NuCana in Q4 2019 and held it in 7 quarters.
  • JP Morgan Chase's NuCana position peaked at $1.53M in Q3 2020.
  • 10 funds tracked by Wall St. Rank held NuCana as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.